¸¶ÀÌÅ©·Î RNA ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
MicroRNA Market with COVID-19 Impact Analysis, By Product & Service, By Application, By End use, By Country, and By Region - Industry Analysis, Market Size,Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1304638
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 305 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,720,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,753,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,206,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ÀÇ ÇÏÀ̶óÀÌÆ®

¸¶ÀÌÅ©·Î RNA ½ÃÀå ±Ô¸ð´Â 2022³â 15¾ï 5,540¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 13.8%·Î È®´ëµÉ °ÍÀÔ´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ½ÃÀå - ½ÃÀå ¿ªÇÐ :

¸¶ÀÌÅ©·Î RNAÀÇ »ç¿ë Áõ°¡¿Í ±â¼ú Çõ½ÅÀ¸·Î ¼ö¿ä ±ÞÁõ

¹ÙÀÌ¿À¸¶Ä¿·Î¼­ ¸¶ÀÌÅ©·Î RNAÀÇ »ç¿ëÀÌ Áõ°¡Çϸ鼭 ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¹ÙÀÌ¿À¸¶Ä¿´Â ±âÁ¸ ÀýÂ÷¿¡ ºñÇØ ÀçÇö¼º°ú °ß°í¼ºÀÌ ¶Ù¾î³ª µ¥ÀÌÅÍ ±â¹Ý ¹æ¹ý·Ð°ú °Ô³ð Â÷¿øÀÇ Áý´Ü ¿¬±¸¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. µû¶ó¼­ ¹ÙÀÌ¿À¸¶Ä¿ °³¹ß¿¡¼­ ÀÌ·¯ÇÑ ºÐÀÚ´Â À¯¸ÁÇÑ ¾à¹° Èĺ¸¹°ÁúÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾×ü ±â¹Ý »ý°Ë¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¹× °³¹ß¿¡¼­ ±× Á߿伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¸¶ÀÌÅ©·Î RNAÀÇ µ¶¼º°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ³í¶õÀÇ ¿©Áö°¡ ÀÖ°í, ¸¶ÀÌÅ©·Î RNAÀÇ ³ôÀº ºñ¿ëÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¶ÀÌÅ©·Î RNA °ËÃâÀÇ ¼±Åüº°ú ¹Î°¨µµ¸¦ Çâ»ó½Ã۱â À§ÇÑ ±â¼ú Çõ½ÅÀÌ ¸¶ÀÌÅ©·Î RNA ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. »õ·Î °³¹ßµÈ ¸¶ÀÌÅ©·Î RNA °ËÃâ ¹æ¹ý¿¡´Â DSN ±â¹Ý, ³ª³ëÀÔÀÚ ±â¹Ý ÁõÆø¹ý, È¿¼Ò°¡ ¾ø´Â ÁõÆø¹ý, RCA ±â¹Ý µîÀÌ ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ¿¬±¸ÀÚµéÀº miRNAÀÇ Á¤·®Àû, ƯÀÌÀû µðÁöÅÐ ÃøÁ¤À» À§ÇØ ÇÁ·Î±×·¥ ±â¹Ý µî¿ÂÁõÆø ±â¼úÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î PCR ±â¹Ý Á¢±Ù¹ýó·³ Ç¥Àû ¼­¿­À» Á÷Á¢ º¹Á¦ÇÏ´Â °ÍÀÌ ¾Æ´Ï¶ó ½ÅÈ£ ÁõÆøÀ» ±â¹ÝÀ¸·Î Çϱ⠶§¹®¿¡ ¿À¿°À» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸¶ÀÌÅ©·Î RNA ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ¸¶ÀÌÅ©·Î RNA ½ÃÀåÀº Á¦Ç° ¹× ¼­ºñ½º, ¿ëµµ, ±â¼ú ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° ¹× ¼­ºñ½º¸¦ ±âÁØÀ¸·Î Á¦Ç°, ¼Ò¸ðǰ, ¼­ºñ½º ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. ¼­ºñ½º ºÐ¾ß°¡ ½ÃÀå Á¡À¯À²À» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼­ºñ½º Áß¿¡¼­´Â ±¹¼ÒÈ­ ¹× Á¤·®È­ ¼­ºñ½º¿Í ÇÁ·ÎÆÄÀϸµ ¼­ºñ½º°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, PCR Àåºñ´Â »ý¸í°úÇÐ ¿¬±¸¿¡¼­ miRNA Á¤·®È­¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¶ÇÇÑ NGS, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, ½Ç½Ã°£ PCRÀº miRNA ÇÁ·ÎÆÄÀϸµ¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ¹æ¹ý Áß ÀϺÎÀÔ´Ï´Ù.

½ÃÀåÀº ÀÀ¿ë ºÐ¾ß¿¡ µû¶ó ¾Ï, °¨¿°¼º Áúȯ, ¸é¿ª Áúȯ, ½ÉÇ÷°ü Áúȯ, ½Å°æ Áúȯ, ±âŸ 5°¡Áö Ä«Å×°í¸®·Î ºÐ·ùµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå Á¡À¯À²ÀÌ °¡Àå ³ôÀº ºÐ¾ß´Â ¾Ï ºÐ¾ß·Î, miRNA ½Ã±×´Ïó¸¦ Ȱ¿ëÇÑ ¾Ï ¿¬±¸¿¡ ´ëÇÑ ³ôÀº ÅõÀÚ·Î ÀÎÇØ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» º¸À̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ÏÀÇ ¾ÆÇü°ú º´±â¸¦ ±¸ºÐÇϱâ À§ÇÑ ÀÓ»ó Áø´Ü °Ë»ç¿Í miRNA ±â¹Ý Ä¡·á¹ý¿¡ ´ëÇÑ ÀÓ»ó½ÃÇèÀÇ ¹ßÀüÀÌ ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó »ý¸í°øÇÐ ¹× Á¦¾à ±â¾÷, Çмú ¹× Á¤ºÎ ¿¬±¸±â°ü, ±âŸ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÇÐ°è ¹× Á¤ºÎ ¿¬±¸±â°üÀÌ ¿ìÀ§¸¦ Á¡ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀÌ ºÎ¹®Àº miRNA ½ÃÀåÀÇ Áß¿äÇÑ ¼öÀÍ¿øÀ̸ç, miRNA °ü·Ã Á¦Ç° ¹× ±â¼úÀº ÁÖ·Î ÇÐ°è ¹× ¿¬±¸ ±â°ü¿¡¼­ ¼öÇàÇÏ´Â ´Ù¾çÇÑ ¿¬±¸¿¡ »ç¿ëµË´Ï´Ù. ÀÌ¿¡ µû¶ó ¿¬±¸ °Ç¼ö Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ½ÃÀå - Áö¸®Àû ÅëÂû·Â

Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ³ª´¹´Ï´Ù. ÀÌ Áö¿ªÀº »ç¾÷ ¿î¿µ ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ½ÃÀå - °æÀï ±¸µµ:

ÀÌ ¾÷°è ½ÃÀå ÁøÀÔÀÚµéÀº ³ôÀº ƯÀ̼º, ÀçÇö¼º ¹× Á¢±Ù¼ºÀ» °®Ãá »õ·Î¿î ±â±â, ŰƮ ¹× µµ±¸ °³¹ß¿¡ Áö¼ÓÀûÀ¸·Î ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿Á¾¾÷°èÀÇ ´Ù¸¥ ¾÷üµéÀº ¼¼°è À¯Åë¸Á ±¸Ãà¿¡ ÁÖ·ÂÇÏ´Â ÇÑÆí, »õ·Î¿î »ý¹°ÇÐÀû Á¦Á¦¸¦ Ãâ½ÃÇÏ¿© ¹ßÆÇÀ» ¸¶·ÃÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ±× ÈÄ, ƯÈ÷ ¼±Áø±¹¿¡¼­ ¹«±â ¼ºÀå¿¡ ÃÊÁ¡À» ¸ÂÃß°í ½ÃÀå ±â¾÷Àº ¿¹ÃøÇÒ ¼ö ¾ø´Â ¼Óµµ·Î È®ÀåÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù, MiRXES´Â Àδõ½ºÆ®¸® 4.0(i4.0) Á¦Á¶ ½Ã¼³, µÎ °³ÀÇ »õ·Î¿î ¿¬±¸¼Ò, ¿©·¯ ¾Ï ¼±º° °øµ¿ ¿¬±¸ ÇÁ·ÎÁ§Æ® µî ÀÏ·ÃÀÇ »õ·Î¿î ±â´ÉÀ» Ãâ½ÃÇß½À´Ï´Ù. ¶ÇÇÑ, miRNA ±â¹Ý Áúº´ °ËÃâ Å×½ºÆ®¸¦ °³¹ßÇϱâ À§ÇÑ »õ·Î¿î °³¹ßÀº MiRXESÀÇ »ý»ê ¹× ¿¬±¸ ´É·ÂÀ» Çâ»ó½ÃŰ·Á´Â ¸ñÇ¥¿¡ ºÎÇÕÇÕ´Ï´Ù.

ÃÖ±ÙÀÇ ¹ßÀü

¿¹¸¦ µé¾î, 2023³â 1¿ù ¹ÙÀÌ¿ÀÅ×Å©³×´Â Advanced Cell Diagnostics(ACD) ºê·£µåÀÇ RNAscope(TM) in situ hybridization(ISH) Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϱâ À§ÇØ RNAscope Plus smRNA-RNA °ËÃ⠺м®¹ýÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ºÐ¼®¹ýÀº ´ë±Ô¸ð ¿¬±¸¸¦ Áö¿øÇϱâ À§ÇØ ½±°Ô È®ÀåÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ¶óÀÌÄ«º»µå Rx Ç÷§Æû¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â ¼öµ¿ ºÐ¼®¹ýÀ¸·Î Á¦°øµË´Ï´Ù.

Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ ¸¶ÀÌÅ©·Î RNA ½ÃÀå Á¶»ç ¿¬±¸´Â 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ½ÃÀå ±Ô¸ð, CAGR, ÃßÁ¤ ¹× ¿¹Ãø(2023-2030³â)À» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â °í°´¿¡°Ô ¸¶ÀÌÅ©·Î RNA ½ÃÀå¿¡ ´ëÇÑ Ãֽе¿Çâ¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â ´Ù¾çÇÑ ºÎ¹®/±¹°¡¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ¸¶ÀÌÅ©·Î RNA ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â Àü¹ÝÀûÀÎ º¸°í¼­¿¡¼­ »õ·Î¿î ÅõÀÚ ±âȸ, ±âÁ¸ ±â¾÷ÀÌ Á÷¸éÇÑ °úÁ¦, ¸¶ÀÌÅ©·Î RNA ½ÃÀå¿¡¼­ Áö¼Ó °¡´ÉÇÑ ¼ºÀå ¿äÀÎÀ» ÆÄ¾ÇÇÕ´Ï´Ù.

COVID-19°¡ ¸¶ÀÌÅ©·Î RNA ½ÃÀå ±Ô¸ð, ¿¹Ãø, CAGR ¹× ½ÃÀå ¿ªÇп¡ ¹ÌÄ¡´Â ¿µÇâÀº ¿¬±¸ ¹üÀ§¿¡¼­ ÀÚ¼¼È÷ ³íÀǵǸç, COVID ÀÌÈÄ ¸¶ÀÌÅ©·Î RNA ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Âµµ ´Ù·ì´Ï´Ù.

ÀÌ º¸°í¼­´Â »ç¿ëÀÚ¿¡°Ô ¸¶ÀÌÅ©·Î RNA ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °üÁ¡À» Á¦°øÇϱâ À§ÇØ ¸¶ÀÌÅ©·Î RNA ½ÃÀå °æÀï ±¸µµ¿Í ÁÖ¿ä Çõ½Å°¡ ºÐ¼®µµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ½ÃÀå ±Ô¸ð, ¼ºÀå·ü, ¸Å·Âµµ¸¦ ±âÁØÀ¸·Î ¸ðµç »ê¾÷ ºÎ¹®À» º¥Ä¡¸¶Å·ÇÑ ¼ºÀå Àü¸Á ¸ÅÇÎ ºÐ¼®µµ Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ »ó¼¼ÇÑ ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÏ¿© ¸¶ÀÌÅ©·Î RNA ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ±â¾÷ÀÇ À繫 Á¤º¸ ¹× Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¼¼°è»Ó¸¸ ¾Æ´Ï¶ó Áö¿ªÀû Â÷¿ø¿¡¼­µµ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀÇ Áß¿äÇÑ ÀμöÇÕº´, Á¦ÈÞ ¹× ÇÕÀÛÅõÀÚ, ½ÅÁ¦Ç° Ãâ½Ã, ¿¬±¸°³¹ß, Áö¿ªÀû ÁøÃâ µîÀ» È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ¼¼°è ½ÃÀå º¸°í¼­´Â ÁÖ·Î °ø±Þ¾÷ü, ÅõÀÚÀÚ, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À¯Åë ¾÷ü, ±ÝÀ¶ ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¸¶ÀÌÅ©·Î RNA ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¸¶ÀÌÅ©·Î RNA »ê¾÷ Á¶»ç

Á¦5Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå ±¸µµ

Á¦7Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå - Á¦Ç° ¹× ¼­ºñ½ºº°

Á¦8Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå - ¿ëµµº°

Á¦9Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

Á¦10Àå ¸¶ÀÌÅ©·Î RNA ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¸¶ÀÌÅ©·Î RNA ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ ´Ù°¢Àû °ßÇØ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

MicroRNA Market size was valued at USD 1,555.4 Million in 2022, expanding at a CAGR of 13.8% from 2023 to 2030.

MicroRNAs (miRNAs) are endogenous small RNAs that regulate gene expression post-transcriptionally. MiRNA research in allergy is progressing because miRNAs are essential regulators of gene expression and promising biomarker candidates. Moreover, miRNA inhibitors and mimics are currently in preclinical development as novel therapeutic agents. Furthermore, a rise in research into the potential of miRNA biomarkers in diagnosis, therapeutics, and prognosis is projected to favor market expansion.

MicroRNA Market- Market Dynamics:

Increasing use of microRNA and Technological Innovation surge the demand

As a biomarker increasing the use of microRNA is propelling the market. In addition, these biomarkers are significant in data-driven methods and genome-wide population studies because they have high reproducibility and robustness as compared to traditional procedures. Thereby, for the development of biomarkers such molecules are promising drug candidates. Moreover, rising interest in liquid-based biopsies has raised their importance in biomarker discovery and development. However, their toxicity and safety are controversial issues along with the high cost of microRNA will likely act as a restrain which may hamper the market growth during the forecast period. Furthermore, for improving the selectivity and sensitivity of microRNA detection technological innovation contributes to the microRNA market's growth. The newly developed methods for microRNA detection includes DSN-based, nanoparticle-based amplification, enzyme-free amplification, and RCA-based. Similarly, a program-based isothermal amplification technique is developed by researchers for quantitative and specific digital measurement of miRNA. As a result, the system can minimize contamination as it is based on signal amplification rather than direct replication of the targeted sequence as is done with PCR-based approaches.

MicroRNA Market- Key Insights:

MicroRNA Market- Segmentation Analysis:

The global microrna market is segmented on the basis of product & service, application, technology, and region.

The market is divided into three categories based on product & service: products, consumables, and services. The services segment is expected to dominate the market share. Among services, localization & quantification and profiling services held the largest market share. Moreover, PCR instruments are commonly used in life, and science research for miRNA quantification. Furthermore, NGS, microarrays, and real-time PCR are some of the generic used methods for miRNA profiling.

The market is divided into five categories based on application: cancer, infectious diseases, immunological disorder, cardiovascular disease, neurological diseases, and others. The cancer segment is likely to possess the market share over the forecast period. The high investments in cancer research adopting miRNA signatures are resulting in the highest revenue share. Additionally, clinical diagnostic tests for the differentiation of cancer subtypes & the stage and progress in clinical trials for therapies based on miRNA are attributed to fuel the segment growth.

The market is divided into two categories based on end use: biotechnology & pharmaceutical companies, academic & government research institutes, and others. The academic & government research institutes are likely to maintain their dominance. This segment is the essential revenue generator of the miRNA market. MiRNA-associated products and techniques are majorly used in various research studies that are being conducted by academic and research institutes. As a result, a rising number of research studies are expected to propel the market growth.

MicroRNA Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

MicroRNA Market- Competitive Landscape:

Market participants in this industry are continuously engaged in the development of novel instruments, kits, and tools with high specificity, reproducibility, and accessibility. Moreover, players in the market have announced novel biologics along with shifting their focus on building a well-developed global distribution network to gain a foothold among these peers. After that, the focus shifted towards inorganic growth, specifically in developed nations, allowing market players to expand at unpredictable rates. For instance, in August 2022, MiRXES launched a series of new capabilities-including an Industry 4.0 (i4.0) manufacturing facility, two new laboratories, and a collaborative multi-cancer screening research project. Additionally, to develop miRNA-based disease detection tests the new developments are aligned with MiRXES' goal of advancing its production and research capabilities.

Recent Developments:

For instance, in January 2023, Bio-Techne Corporation introduced the RNAscope Plus smRNA-RNA detection assay for the expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ hybridization (ISH) portfolio. Moreover, it is designed to be easily scalable to assist large studies, the assay will be provided for use on the Leica Bond Rx platform and as a manual assay.

Key features of the study:

This proposed research study on microRNA market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The report provides the client the latest up-to-date and trending insights about the microRNA market.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for microRNA market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the microRNA market

Impact of COVID-19 on microRNA market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on microRNA market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the microRNA market, we have also included competitive landscape and key innovator analysis for the microRNA market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the microRNA market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global microRNA market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICRORNA MARKET KEY PLAYERS

GLOBALMICRORNA MARKET, BY PRODUCT & SERVICE

GLOBAL MICRORNA MARKET, BY APPLICATION

GLOBAL MICRORNA MARKET, BY END USE

GLOBAL MICRORNA MARKET, BY REGION

Table of Contents

1. MicroRNA Market Overview

2. Executive Summary

3. MicroRNA Key Market Trends

4. MicroRNA Industry Study

5. MicroRNA Market : COVID-19 Impact Analysis

6. MicroRNA Market Landscape

7. MicroRNA Market - By Product & Service

8. MicroRNA Market - By Application

9. MicroRNA Market - By End use

10. MicroRNA Market- By Geography

11. Key Vendor Analysis- MicroRNA Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â